Stock Events

Stock Events

Fulcrum Therapeutics (FULC) Q4 2023 Earnings

27FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.46

-0.43

-0.41

-0.38

Details

Expected EPS

-0.425714

Actual EPS

-0.4

Surprise EPS

0.03

Surprise Percent

+6.04%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.4 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.